Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
CLOSE
X
HOME CAPABILITIES Why Single Cell SNV SNV + CNV DNA + Protein Applications Oncology Research Multiple Myeloma AML MRD Precision Medicine Genome Editing Genome Integrity Assay Biomarker Development Cell and Gene Therapy Products & Services Tapestri Platform Panels Pharma Assay Development PAD for Cell & Gene Therapy PAD for Drug Development
RESOURCES BLOG PODCAST COMPANY About Us Careers Newsroom Events Distributors & Service Providers SUPPORT CENTER CONTACT PORTAL
X
Home Publication Database Late-onset NPM1 mutation in a MYC-amplified relapsed / refractory acute myeloid leukemia…
FILTER RESOURCES
ALL FEATURED PUBLICATIONS SCIENTIFIC PRESENTATIONS RESEARCHER SPOTLIGHTS VIDEOS BROCHURES DATASETS USER GUIDES TECHNICAL NOTES POSTERS EBOOKS

Publications

Late-onset NPM1 mutation in a MYC-amplified relapsed / refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib


Sonia Jaramillo, Michael Scherer, Chelsea Szu-Tu, Sergi Beneyto-Calabuig, Carsten Müller-Tidow, Richard F Schlenk, Michael Hundemer, Lars Velten, Caroline Pabst
Haematologica May 2024
Abstract

Not available.

VIEW

Area

Heme

Institution Type

Academia

Indication / Modality

Acute Myleoid Leukemia, Acute Myleoid Leukemia (AML)

Key Genes

NPM1

PAD Project

No
SIGN UP FOR PRODUCT AND EVENT UPDATES
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
CAPABILITIES
Why Single Cell SNV SNV + CNV DNA + Protein
APPLICATIONS
Oncology Research Multiple Myeloma AML MRD Precision Medicine Genome Editing Biomarker Development Cell and Gene Therapy
PRODUCTS & SERVICES
Tapestri Platform Panels Pharma Assay Development PAD for Cell & Gene Therapy PAD for Drug Development
COMPANY CAREERS NEWSROOM EVENTS BLOG RESOURCES SUPPORT CENTER CONTACT Terms of Use Privacy Policy Terms and Conditions of Sale Client Data Security & Retention
REQUEST QUOTE